Immunocore Holdings plc (IMCR) Misses Q2 EPS by 2c

Immunocore Holdings plc (NASDAQ: IMCR) reported Q2 EPS of ($0.20), $0.02 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $98 million versus the consensus estimate of $92.04 million.

For earnings history and earnings-related data on Immunocore Holdings plc (IMCR) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• Jefferies sees metals breakout on currency concerns
• ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)